গুৱাহাটী টাইমচ
Covaxin manufacture Bharat Biotech on Saturday said that the booster dose trials have shown “promising results” of long-term safety with “no serious adverse events”. The Hyderabad-based company announced the results on the safety and immunogenicity of COVAXIN (BBV152), a whole-virion inactivated COVID-19 vaccine as a booster dose. “Covaxin trial demonstrated
Assam reported 1,254 new COVID-19 cases during the last 24 hours, said the state health department on Saturday. With this, the total cases of COVID-19 in the state mounted to 6,25,753. The active caseload in the state stands at 4,548. A total of 33,609 samples were tested during the last
Amid surge in COVID-19 cases, Assam government announce a new set of Standard Operating Procedure (SOP) on Friday, which is expected to put restrictions on big gatherings and change in curfew timings. Here are the key restrictions for School/College. • All schools upto Class VIII in Kamrup-Metropolitan district and upto
THE NEW SOP WILL BE AS FOLLOWS: •No Free Treatment will be provided by Assam Government for COVID Patients from now onwards, however, People from the BPL category have been exempted. •All Schools up to class V in Assam will be closed from January 8 to January 30. In Guwahati,
ক’ভিড-19এ পুনৰ ভয়াৱহ ৰূপ ধাৰণ কৰিছে যদিও অসমত লক ডাউন ঘোষণা নকৰাৰ সিদ্ধান্ত গ্ৰহণ কৰিছে ৰাজ্য চৰকাৰে ৷ বৃহস্পতিবাৰে মুখ্যমন্ত্ৰী হিমন্ত বিশ্ব শৰ্মাই সংবাদ মাধ্যমৰ জৰিয়তে ঘোষণা কৰে এই কথা । মুখ্যমন্ত্ৰীগৰাকীয়ে কয় যে, লক ডাউন ঘোষণা কৰা নহয় যদিও সাধাৰণ লোকৰ জীৱন আৰু জীৱিকাৰ যাতে কোনোধৰণৰ ক্ষতি নহয় তাৰ